NEC OncoImmunity

EUIPO EUIPO 2019 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark NEC OncoImmunity was filed as Word mark on 07/02/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/20/2019. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 4, 2022

Trademark form Word mark
File reference 018090687
Application date July 2, 2019
Publication date September 11, 2019
Entry date December 20, 2019
Expiration date July 2, 2029

Trademark owner

7-1, Shiba 5-chome, Minato-ku
108-8001 Tokyo
JP

Trademark representatives

Edificio Torre de Cristal Pº de la Castellana 259C, planta 28 28046 Madrid ES

goods and services

9 Computer software; computer software for use in predicting data; computer software for use in predicting data in the field of artificial intelligence; computer software for prediction using machine-Ieaning engine; computer software for predicting neoantigens; computer software for predicting immunogenic neoantigens for personalized cancer immunotherapy; computer software that predicts from next generation sequencing data true neoantigens for personalized cancer immunotherapy and cancer immunotherapy biomarkers; computer software for prediction of antigens that are naturally processed and presented to the tumor cell surface; computer software for predicting HLA genotyping; computer software for use in optimization of somatic variant detection rates
42 Research and development relating to technology in the field of artificial intelligence; design and development of computer software; computer software consultancy; computer programming; installation, maintenance and repair of computer software; technological research; Cloud computing; Software as a service (SaaS); providing on-line non-downloadable software for predicting neoantigens; providing on-line non-downloadable software for predicting HLA genotyping; providing on-Iine non-downloadable software for use in optimization of somatic variant detection rates; medical research

Trademark history

Date Document number Area Entry
February 3, 2022 Change Representative, Published

ID: 11018090687